Actualités Churchill Capital Corp VII - CVII | Actions New York Stock Exchange | ADVFN

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Churchill Capital Corp VII (CVII)
Churchill Capital Corp VII (CVII) Actualités

Churchill Capital Corp VII (CVII)

10,60

0,00

(0,00%)

Fermé 21 Février 10:00PM

Retardé de 15 minutes

0,00

0,00

(0,00%)

Après les heures de négociation: -

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 425 - Prospectuses and communications, business combinations

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 425 - Prospectuses and communications, business combinations

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant...

Form DEFM14A - Definitive proxy statement relating to merger or acquisition

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 425 - Prospectuses and communications, business combinations

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Churchill Capital Corp VII

Vontobel Financial Produ...

Akero Therapeutics

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales